Abstract
The method of measuring changes in the structuredness of SCM in single cells is described. Data on SCM distributions and fractions of human lymphocyte populations which respond to stimulations with PHA [phytohemagglutinin] and CaBP [cancer basic protein] in healthy donors and patients with malignant disorders are presented.